RECRUITING

North American Prodromal Synucleinopathy Consortium Stage 2

Talk to us

Conditions

REM Sleep Behavior DisorderParkinson DiseaseLewy Body DementiaDementia With Lewy BodiesMultiple System AtrophyREM Sleep Parasomnias

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study will enroll participants with idiopathic REM sleep behavior disorder (RBD) and healthy controls for the purpose of preparing for a clinical trial of neuroprotective treatments against synucleinopathies.

Official Title

North American Prodromal Synucleinopathy Consortium Stage 2

Quick Facts

Study Start:2022-08-12
Study Completion:2025-05-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05826457

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. Age 18 years or older
  2. Willing and able to provide informed consent
  3. Able to understand and follow study procedures
  4. Stable medical condition
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

Jennifer McLeland, PhD
CONTACT
314-747-3819
mclelandj@wustl.edu
Leah Taylor
CONTACT
314-747-7297
ltaylor24@wustl.edu

Principal Investigator

Yo-El Ju, MD, MCSI
PRINCIPAL_INVESTIGATOR
Washington University School of Medicine
Brad Boeve, MD
PRINCIPAL_INVESTIGATOR
Mayo Clinic
Ron Postuma, MD
PRINCIPAL_INVESTIGATOR
McGill University

Study Locations (Sites)

University of California Los Angeles
Los Angeles, California, 90095
United States
Stanford University
Redwood City, California, 94063
United States
Emory University
Atlanta, Georgia, 30322
United States
Massachusetts General Hospital
Boston, Massachusetts, 02145
United States
University of Minnesota
Minneapolis, Minnesota, 55414
United States
Mayo Clinic Rochester
Rochester, Minnesota, 55905
United States
Washington University School of Medicine
Saint Louis, Missouri, 63110
United States
Oregon Health Sciences University
Portland, Oregon, 97239
United States

Collaborators and Investigators

Sponsor: Washington University School of Medicine

  • Yo-El Ju, MD, MCSI, PRINCIPAL_INVESTIGATOR, Washington University School of Medicine
  • Brad Boeve, MD, PRINCIPAL_INVESTIGATOR, Mayo Clinic
  • Ron Postuma, MD, PRINCIPAL_INVESTIGATOR, McGill University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-08-12
Study Completion Date2025-05-01

Study Record Updates

Study Start Date2022-08-12
Study Completion Date2025-05-01

Terms related to this study

Additional Relevant MeSH Terms

  • REM Sleep Behavior Disorder
  • Parkinson Disease
  • Lewy Body Dementia
  • Dementia With Lewy Bodies
  • Multiple System Atrophy
  • REM Sleep Parasomnias